Aluna ’s Post

Last day of the 2024 Aspen Allergy Conference will highlight three important topics, AI , Social Media and Telehealth in Allergy and Immunology. Informative and practical…

According to the American Academy of Allergy Asthma & Immunology, the allergy injection ramp up phase can last up to 6-7 months! 😳 Why make your patients wait that long for #allergy relief? Instead, opt for a treatment that can deliver results in as little as FOUR WEEKS for adults and children as young as 3 1/2. See how Circava System™️ therapy can provide relief sooner! https://lnkd.in/gKxsHGTN #allergyrelief #immunology #potens

What are the pros and cons of dual accreditation in both rheumatology and allergy immunology? Our latest guest, Dr. Bharat Kumar, gives us his insights. Listen → acrjournalsonair.org

Meet the Researchers Behind the Science! Allergy-TV features video abstracts created by the authors of our latest articles. Get insights directly from the experts on groundbreaking research in allergy, asthma, and immunology. Why Subscribe? - Direct insights from leading researchers - Easy-to-understand summaries of cutting-edge research - Stay updated on the latest advancements 👉 Subscribe to Allergy-TV and stay at the forefront of allergy research: https://lnkd.in/g7V4h4nd #AllergyResearch #Asthma #Immunology #ScientificJournal #Allergy_journal

USP 797 is now in effect. How well are you and your practice prepared for documenting and reporting the quality and safety of the compounded antigens in your allergy department? You can learn more in this podcast from the American Academy of Asthma Allergy and Immunology. #aaaai24

Scribe Align provides expert Allergy and Immunology billing solutions for efficiency and accuracy. Partner with us to focus more on patient care. #MedicalBilling #AllergyBilling #ImmunologyBilling #HealthcareAdmin #RevenueCycleManagement #MedicalPractice #PatientCare #BillingEfficiency #HealthcareSolutions #ScribeAlign #scribealignllc #scribe

Rates of new peanut allergy and discontinuation after introduction appeared low in a cohort of high-risk infants. https://lnkd.in/eUCtVF9u

Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by lead author Richard K. Gurgel, MD, MSC and author Stacey L. Ishman, MD, MPH for a discussion of the implications for otolaryngologists of the article “Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.” They discuss how the CPG came together over two years and what they discovered comparing different types of immunotherapy and the effects on different patient populations.#ClinicalPracticeGuideline #CPG #immunotherapy #allergy #otolaryngology #ENT https://lnkd.in/et3uWU5z

COVID-19 and Asthma A recent study (Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort Study B. Kim, et al: J Allergy Clin Immunol Pract 2024;12:120-32) was done looking at rates of asthma and COVID. We already had known that COVID was less severe in most patients who already had asthma, who were taking inhaled corticosteroids. This article showed that people who got sick with COVID doubled the risk of developing asthma. The COVID vaccine did not cause asthma. People who were vaccinated did not have this increased risk of developing asthma, since they were less likely to develop COVID.

On July 16 the Allergy and Asthma network is offering a free webinar concerning Health Disparities in Allergy, Asthma, and Immunologic Diseases. This talk is designed to communicate some of the innovations developed concerning asthma treatment that have not been properly communicated to the public, particularly among under-resourced communities. These communities are often disproportionately impacted by airway issues. https://bit.ly/3VNiEgx